Share on StockTwits

Delcath Systems (NASDAQ:DCTH) traded up 4.2% during trading on Thursday following a stronger than expected earnings report, AR Network reports. The company traded as high as $3.24 and last traded at $3.20, with a volume of 164,634 shares changing hands. The stock had previously closed at $3.07.

The company reported ($0.57) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.64) by $0.07. The company had revenue of $0.31 million for the quarter, compared to the consensus estimate of $0.20 million. The company’s revenue for the quarter was down 18.4% on a year-over-year basis.

Separately, analysts at Zacks upgraded shares of Delcath Systems from a “neutral” rating to an “outperform” rating in a research note on Tuesday, March 25th. They now have a $0.40 price target on the stock.

The stock has a 50-day moving average of $4.23 and a 200-day moving average of $4.73. The company’s market cap is $26.3 million.

Delcath Systems, Inc (NASDAQ:DCTH) is a development-stage company that has developed a system designed to administer high dose chemotherapy and other therapeutic agents to diseased organs or regions of the body.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.